Baxano Overview

  • Founded
  • 2005
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 40
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $23.6M
Latest Deal Amount

Baxano General Information

Description

Developer of minimally invasive tools to restore spine function and preserve healthy tissue. The company offers iO-Flex System, which targets and decompresses bone and soft tissue in the foramen, lateral recess and central canal for patients with single and multi-level mild, moderate and severe stenosis. Its products comprise Neuro Check device that allows the surgeon to confirm that the device is against the bone and the nerve is safely out of the way; MicroBlade ShaverTM instrument, which is used to remove the impinging bone and ligament; Guidewire; probes and distal handles.

Contact Information

Website
www.baxano.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Surgical Devices
Acquirer
Baxano Surgical
Primary Office
  • 655 River Oaks Parkway
  • San Jose, CA 95134
  • United States
+1 (408) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Baxano Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 03-Jun-2013 $23.6M 000.00 000.00 Completed Generating Revenue
3. Later Stage VC (Series C) 22-Jun-2010 0000 000.00 000.00 Completed Generating Revenue
2. Early Stage VC (Series B) 28-Jul-2008 $20M $28.8M 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 10-Jan-2007 $8.83M $8.83M 000.00 Completed Product Development
To view Baxano’s complete valuation and funding history, request access »

Baxano Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series C 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series B 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A2 2,911,038 $0.001000 $0.13 $1.65 $1.65 1x $1.24 5.18%
Series A1 4,024,286 $0.001000 $0.08 $1 $1 1x $0.95 5.65%
To view Baxano’s complete cap table history, request access »

Baxano Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of minimally invasive tools to restore spine function and preserve healthy tissue. The company offers iO-Flex
Surgical Devices
San Jose, CA
40 As of 2010
000.00
00.00 0000-00-00
000000&0 000.00

000 0000

ua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo
00000000 0000000
Austin, TX
000 As of 0000
00000
0.000 0000-00-00
000000&0 00000

00000000

ion ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit
00000000 0000000
San Diego, CA
0000 As of 0000
00000
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Baxano Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
LDR Holding Formerly VC-backed Austin, TX 000 00000 000000&0 00000
00000000 Formerly VC-backed San Diego, CA 0000 00000 000000&0
00000 0000 Venture Capital-Backed Shelton, CT 000 00000 00000000000 00000
00000000 000000000 Venture Capital-Backed Naples, FL 00 000.00 00000000000 000.00
0000 0000000000 Formerly VC-backed Minnetonka, MN 00 000.00 000000&0 000.00
You’re viewing 5 of 8 competitors. Get the full list »

Baxano Patents

  • 68

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 7

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Baxano Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20110259855-A1 Plasma torch electrode with improved cooling capability Abandoned 21-Apr-2010 00000000 00
AU-2010246130-B2 Tissue modification devices and methods Ceased 04-May-2009 0000000000000
AU-2010246130-A1 Tissue modification devices and methods Granted 04-May-2009 0000000000000
CA-2760925-A1 Tissue modification devices and methods Abandoned 04-May-2009 0000000000000
EP-2427129-A2 Tissue modification devices and methods Withdrawn 04-May-2009 A61B17/320016
To view Baxano’s complete patent history, request access »

Baxano Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Baxano Former Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Affinity Capital Management Venture Capital Minority 000 0000 000000 0
Athenian Venture Partners Venture Capital Minority 000 0000 000000 0
Kaiser Permanente Ventures Corporate Venture Capital Minority 000 0000 000000 0
Kearny Venture Partners Venture Capital Minority 000 0000 000000 0
Pinnacle Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial